BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: O'Sullivan KE, Phelan JJ, O'Hanlon C, Lysaght J, O'Sullivan JN, Reynolds JV. The role of inflammation in cancer of the esophagus. Expert Rev Gastroenterol Hepatol. 2014;8:749-760. [PMID: 24857183 DOI: 10.1586/17474124.2014.913478] [Cited by in Crossref: 39] [Cited by in F6Publishing: 43] [Article Influence: 4.9] [Reference Citation Analysis]
Number Citing Articles
1 Kubo Y, Tanaka K, Yamasaki M, Yamashita K, Makino T, Saito T, Yamamoto K, Takahashi T, Kurokawa Y, Motoori M, Kimura Y, Nakajima K, Eguchi H, Doki Y. The Impact of Perioperative Fluid Balance on Postoperative Complications after Esophagectomy for Esophageal Cancer. JCM 2022;11:3219. [DOI: 10.3390/jcm11113219] [Reference Citation Analysis]
2 Shim S, Lee S, Hisham Y, Kim S, Nguyen TT, Taitt AS, Hwang J, Jhun H, Park HY, Lee Y, Yeom SC, Kim SY, Kim YG, Kim S. A Paradoxical Effect of Interleukin-32 Isoforms on Cancer. Front Immunol 2022;13:837590. [PMID: 35281008 DOI: 10.3389/fimmu.2022.837590] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Parsa N, Kahn A. Impact of obesity on Barrett’s esophagus and esophageal adenocarcinoma. Obesity and Esophageal Disorders 2022. [DOI: 10.1016/b978-0-323-98365-5.00001-2] [Reference Citation Analysis]
4 Mylod E, O’connell F, Donlon NE, Butler C, Reynolds JV, Lysaght J, Conroy MJ. The Omentum in Obesity-Associated Cancer: A Hindrance to Effective Natural Killer Cell Migration towards Tumour Which Can Be Overcome by CX3CR1 Antagonism. Cancers 2021;14:64. [DOI: 10.3390/cancers14010064] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Maslyonkina KS, Konyukova AK, Alexeeva DY, Sinelnikov MY, Mikhaleva LM. Barrett's esophagus: The pathomorphological and molecular genetic keystones of neoplastic progression. Cancer Med 2021. [PMID: 34870375 DOI: 10.1002/cam4.4447] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
6 Kennedy SA, Annett SL, Dunne MR, Boland F, O'Neill LM, Guinan EM, Doyle SL, Foley EK, Elliott JA, Murphy CF, Bennett AE, Carey M, Hillary D, Robson T, Reynolds JV, Hussey J, O'Sullivan J. Effect of the Rehabilitation Program, ReStOre, on Serum Biomarkers in a Randomized Control Trial of Esophagogastric Cancer Survivors. Front Oncol 2021;11:669078. [PMID: 34604026 DOI: 10.3389/fonc.2021.669078] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Zhu C, Xia Q, Gu B, Cui M, Zhang X, Yan W, Meng D, Shen S, Xie S, Li X, Jin H, Wang S. Esophageal Cancer Associated Immune Genes as Biomarkers for Predicting Outcome in Upper Gastrointestinal Tumors. Front Genet 2021;12:707299. [PMID: 34349789 DOI: 10.3389/fgene.2021.707299] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 5.0] [Reference Citation Analysis]
8 van Hootegem SJM, Smithers BM, Gotley DC, Brosda S, Thomson IG, Thomas JM, Gartside M, Barbour AP. Baseline neutrophil-lymphocyte ratio holds no prognostic value for esophageal and junctional adenocarcinoma in patients treated with neoadjuvant chemotherapy. Dis Esophagus 2020;33:doz082. [PMID: 31676907 DOI: 10.1093/dote/doz082] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
9 King R, Hayes C, Donohoe CL, Dunne MR, Davern M, Donlon NE. Hypoxia and its impact on the tumour microenvironment of gastroesophageal cancers. World J Gastrointest Oncol 2021; 13(5): 312-331 [PMID: 34040696 DOI: 10.4251/wjgo.v13.i5.312] [Cited by in CrossRef: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
10 Chen S, Cao R, Liu C, Tang W, Kang M. Investigation of IL-4, IL-10, and HVEM polymorphisms with esophageal squamous cell carcinoma: a case-control study involving 1929 participants. Biosci Rep 2020;40:BSR20193895. [PMID: 32744314 DOI: 10.1042/BSR20193895] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
11 Elliott JA, Reynolds JV. Visceral Obesity, Metabolic Syndrome, and Esophageal Adenocarcinoma. Front Oncol 2021;11:627270. [PMID: 33777773 DOI: 10.3389/fonc.2021.627270] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 10.0] [Reference Citation Analysis]
12 Tian C, Chen K, Gong W, Yoshimura T, Huang J, Wang JM. The G-Protein Coupled Formyl Peptide Receptors and Their Role in the Progression of Digestive Tract Cancer. Technol Cancer Res Treat 2020;19:1533033820973280. [PMID: 33251986 DOI: 10.1177/1533033820973280] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
13 Diakowska D, Krzystek-Korpacka M. Local and Systemic Interleukin-32 in Esophageal, Gastric, and Colorectal Cancers: Clinical and Diagnostic Significance. Diagnostics (Basel) 2020;10:E785. [PMID: 33020452 DOI: 10.3390/diagnostics10100785] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
14 Hu L, Zhang C, Yang K, Li M, Shaker A. Human esophageal myofibroblasts increase squamous epithelial thickness via paracrine mechanisms in an in vitro model of gastroesophageal reflux disease. PLoS One 2020;15:e0238852. [PMID: 32925965 DOI: 10.1371/journal.pone.0238852] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
15 Han P, Cao P, Hu S, Kong K, Deng Y, Zhao B, Li F. Esophageal Microenvironment: From Precursor Microenvironment to Premetastatic Niche. Cancer Manag Res 2020;12:5857-79. [PMID: 32765088 DOI: 10.2147/CMAR.S258215] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 5.5] [Reference Citation Analysis]
16 Shang QX, Yang YS, Hu WP, Yuan Y, He Y, Zhao JY, Ji AF, Chen LQ. Clinical and prognostic significance of preoperative lymphocyte-monocyte ratio, neutrophil-lymphocyte ratio and neutrophil-monocyte ratio on esophageal squamous cell carcinoma patients. Transl Cancer Res 2020;9:3903-14. [PMID: 35117757 DOI: 10.21037/tcr-19-2777] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
17 Gokon Y, Fujishima F, Taniyama Y, Ishida H, Yamagata T, Sawai T, Uzuki M, Ichikawa H, Itakura Y, Takahashi K, Yajima N, Hagiwara M, Nishida A, Ozawa Y, Sakuma T, Sakamoto K, Zuguchi M, Saito M, Kamei T, Sasano H. Glucocorticoid receptor and serum- and glucocorticoid-induced kinase-1 in esophageal adenocarcinoma and adjacent Barrett's esophagus. Pathol Int 2020;70:355-63. [PMID: 32173971 DOI: 10.1111/pin.12922] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
18 Taggart MW, Foo WC, Lee SM. Tumors of the Gastrointestinal System Including the Pancreas. Oncological Surgical Pathology 2020. [DOI: 10.1007/978-3-319-96681-6_12] [Reference Citation Analysis]
19 Han S, Yang Y. Interleukin-32: Frenemy in cancer? BMB Rep 2019;52:165-74. [PMID: 30638183 [PMID: 30638183 DOI: 10.5483/bmbrep.2019.52.3.019] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 3.3] [Reference Citation Analysis]
20 Peters Y, Al-kaabi A, Shaheen NJ, Chak A, Blum A, Souza RF, Di Pietro M, Iyer PG, Pech O, Fitzgerald RC, Siersema PD. Barrett oesophagus. Nat Rev Dis Primers 2019;5. [DOI: 10.1038/s41572-019-0086-z] [Cited by in Crossref: 56] [Cited by in F6Publishing: 61] [Article Influence: 18.7] [Reference Citation Analysis]
21 Zhao S, Jiang Y, Tian T, Zhao J, Xie Y, Chen X, Lu J, Yang F, Li H, Liu K, Dong Z. Jie Du Tong Ye San Prevents N-Nitrosomethylbenzylamine-Induced Esophageal Carcinogenesis via Inhibition of Inflammation and Proliferation. Evid Based Complement Alternat Med 2019;2019:5752670. [PMID: 31236125 DOI: 10.1155/2019/5752670] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
22 Fitzgerald RC, Corley DA. Will a Proton Pump Inhibitor and an Aspirin Keep the Doctor Away for Patients With Barrett's Esophagus? Gastroenterology 2019;156:1228-31. [PMID: 30849313 DOI: 10.1053/j.gastro.2019.03.001] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
23 Cui G, Ren J, Xu G, Li Z, Zheng W, Yuan A. Cellular and clinicopathological features of the IL-33/ST2 axis in human esophageal squamous cell carcinomas. Cancer Cell Int 2018;18:203. [PMID: 30559604 DOI: 10.1186/s12935-018-0700-2] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 2.5] [Reference Citation Analysis]
24 Zhao JJ, Zhou ZQ, Wang P, Chen CL, Liu Y, Pan QZ, Zhu Q, Tang Y, Weng DS, Xia JC. Orchestration of immune checkpoints in tumor immune contexture and their prognostic significance in esophageal squamous cell carcinoma. Cancer Manag Res 2018;10:6457-68. [PMID: 30568505 DOI: 10.2147/CMAR.S181949] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 4.3] [Reference Citation Analysis]
25 Tang L, Shivappa N, Hebert JR, Lee AH, Xu F, Binns CW. Dietary inflammatory index and risk of oesophageal cancer in Xinjiang Uyghur Autonomous Region, China. Br J Nutr 2018;119:1068-75. [PMID: 29502539 DOI: 10.1017/S0007114518000405] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 3.8] [Reference Citation Analysis]
26 Reeh M, Ghadban T, Uzunoglu FG, Nentwich MF, Bockhorn M, Pantel K, Izbicki JR, Vashist YK. Hamburg-Glasgow classification: preoperative staging by combination of disseminated tumour load and systemic inflammation in oesophageal carcinoma. Br J Cancer 2017;117:612-8. [PMID: 28704837 DOI: 10.1038/bjc.2017.219] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
27 Sundaram GM, Veera Bramhachari P. Molecular interplay of pro-inflammatory transcription factors and non-coding RNAs in esophageal squamous cell carcinoma. Tumour Biol 2017;39:1010428317705760. [PMID: 28618941 DOI: 10.1177/1010428317705760] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 2.2] [Reference Citation Analysis]
28 Shivappa N, Hebert JR, Anderson LA, Shrubsole MJ, Murray LJ, Getty LB, Coleman HG. Dietary inflammatory index and risk of reflux oesophagitis, Barrett's oesophagus and oesophageal adenocarcinoma: a population-based case-control study. Br J Nutr 2017;117:1323-31. [PMID: 28571591 DOI: 10.1017/S0007114517001131] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 3.6] [Reference Citation Analysis]
29 Santos AA Jr, Cappellari AR, de Marchi FO, Gehring MP, Zaparte A, Brandão CA, Lopes TG, da Silva VD, Pinto LFR, Savio LEB, Moreira-Souza ACA, Coutinho-Silva R, Paccez JD, Zerbini LF, Morrone FB. Potential role of P2X7R in esophageal squamous cell carcinoma proliferation. Purinergic Signal 2017;13:279-92. [PMID: 28397110 DOI: 10.1007/s11302-017-9559-2] [Cited by in Crossref: 14] [Cited by in F6Publishing: 16] [Article Influence: 2.8] [Reference Citation Analysis]
30 Kaakoush NO, Lecomte V, Maloney CA, Morris MJ. Cross-talk among metabolic parameters, esophageal microbiota, and host gene expression following chronic exposure to an obesogenic diet. Sci Rep 2017;7:45753. [PMID: 28362001 DOI: 10.1038/srep45753] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 3.0] [Reference Citation Analysis]
31 Guinan EM, Doyle SL, O’neill L, Dunne MR, Foley EK, O’sullivan J, Reynolds JV, Hussey J. Effects of a multimodal rehabilitation programme on inflammation and oxidative stress in oesophageal cancer survivors: the ReStOre feasibility study. Support Care Cancer 2017;25:749-56. [DOI: 10.1007/s00520-016-3455-0] [Cited by in Crossref: 28] [Cited by in F6Publishing: 29] [Article Influence: 4.7] [Reference Citation Analysis]
32 Gallerani G, Fabbri F. Circulating Tumor Cells in the Adenocarcinoma of the Esophagus. Int J Mol Sci 2016;17:E1266. [PMID: 27527155 DOI: 10.3390/ijms17081266] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 1.5] [Reference Citation Analysis]
33 Richmond E, Umar A. Mechanisms of esophageal adenocarcinoma formation and approaches to chemopreventive intervention. Semin Oncol 2016;43:78-85. [PMID: 26970126 DOI: 10.1053/j.seminoncol.2015.12.001] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
34 Phelan JJ, Feighery R, Eldin OS, Meachair SÓ, Cannon A, Byrne R, MacCarthy F, O'Toole D, Reynolds JV, O'Sullivan J. Examining the connectivity between different cellular processes in the Barrett tissue microenvironment. Cancer Lett 2016;371:334-46. [PMID: 26688097 DOI: 10.1016/j.canlet.2015.11.041] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
35 Shivappa N, Hébert JR, Rashidkhani B. Dietary Inflammatory Index and Risk of Esophageal Squamous Cell Cancer in a Case-Control Study from Iran. Nutr Cancer 2015;67:1253-9. [PMID: 26400625 DOI: 10.1080/01635581.2015.1082108] [Cited by in Crossref: 36] [Cited by in F6Publishing: 41] [Article Influence: 5.1] [Reference Citation Analysis]
36 Elliott JA, Donohoe CL, Reynolds JV. Obesity and increased risk of esophageal adenocarcinoma. Expert Rev Endocrinol Metab 2015;10:511-23. [PMID: 30298765 DOI: 10.1586/17446651.2015.1077696] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
37 Shivappa N, Zucchetto A, Serraino D, Rossi M, La Vecchia C, Hébert JR. Dietary inflammatory index and risk of esophageal squamous cell cancer in a case-control study from Italy. Cancer Causes Control 2015;26:1439-47. [PMID: 26208592 DOI: 10.1007/s10552-015-0636-y] [Cited by in Crossref: 51] [Cited by in F6Publishing: 51] [Article Influence: 7.3] [Reference Citation Analysis]
38 Lu Y, Shivappa N, Lin Y, Lagergren J, Hébert JR. Diet-related inflammation and oesophageal cancer by histological type: a nationwide case-control study in Sweden. Eur J Nutr 2016;55:1683-94. [PMID: 26189130 DOI: 10.1007/s00394-015-0987-x] [Cited by in Crossref: 32] [Cited by in F6Publishing: 37] [Article Influence: 4.6] [Reference Citation Analysis]
39 Kaakoush NO, Castaño-Rodríguez N, Man SM, Mitchell HM. Is Campylobacter to esophageal adenocarcinoma as Helicobacter is to gastric adenocarcinoma? Trends Microbiol 2015;23:455-62. [PMID: 25937501 DOI: 10.1016/j.tim.2015.03.009] [Cited by in Crossref: 31] [Cited by in F6Publishing: 32] [Article Influence: 4.4] [Reference Citation Analysis]
40 Ji WH, Jiang YH, Ji YL, Li B, Mao WM. Prechemotherapy neutrophil : lymphocyte ratio is superior to the platelet : lymphocyte ratio as a prognostic indicator for locally advanced esophageal squamous cell cancer treated with neoadjuvant chemotherapy. Dis Esophagus 2016;29:403-11. [PMID: 25625421 DOI: 10.1111/dote.12322] [Cited by in Crossref: 14] [Cited by in F6Publishing: 27] [Article Influence: 2.0] [Reference Citation Analysis]